Osteosarcopenia is a geriatric musculoskeletal syndrome characterized by co-existence of
osteoporosis and sarcopenia (low skeletal muscle mass, strength, and/or functional capacity).
There is strong evidence of overlap between the pathophysiology of osteoporosis and
sarcopenia (muscle-bone crosstalk). This research plan will further explore the relationship
between bone and muscle, and provide new information about effect of osteoporosis medications
on muscle health in older adults who are under treatment for osteoporosis.
Phase:
Phase 4
Details
Lead Sponsor:
Nami Safai Haeri
Collaborators:
National Institute on Aging (NIA) The Claude D. Pepper Older Americans Independence Centers